Eigene Publikationen


Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction.

Kurktschiev PD, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner CM, Bengsch B, Thimme R, Denk G, Zachoval R, Dick A, Spannagl M, Haas J, Diepolder HM, Jung MC, Gruener NH

In: The Journal of Experimental Medicine, 2014 Sep; 211(10):2047-59


Influence of hepatitis C virus infection and high virus serum load on biliary complications in liver transplantation

Horster S, Bäuerlein FJ, Mandel P, Raziorrouh B, Hopf C, Stemmler HJ, Guba M, Angele M, Stangl M, Rentsch M, Frey L, Kaspar M, Kaczmarek I, Eberle J, Nickel T, Gruener N, Zachoval R, Diepolder H

In: Transplant Infectious Disease, 2013 Jun; 15(3):306-13


Therapy of hepatocellular carcinoma before liver transplantation

Guba M, Angele M, Rentsch M, Jauch KW, Zachoval R, Kolligs F, Gerbes A, Bruns CJ

In: Der Chirurg, 2013 May; 84(5):385-90


Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease

Rath T, Hage L, Kügler M, Menendez Menendez K, Zachoval R, Naehrlich L, Schulz R, Roderfeld M, Roeb E

In: PLOS ONE. 2013; 8(3):e58955


Temporary intraoperative porto-caval shunt: useless or beneficial in piggy back liver transplantation?

Pratschke S, Meimarakis G, Bruns CJ, Kaspar M, Prix N, Zachoval R, Guba M, Jauch KW, Loehe F, Angele MK

In: Transplant International, 2013 Jan;26(1):90-8


YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis

Rath T, Roderfeld M, Güler C, Wenzel C, Graf J, Beitinger F, Roeb E, Zachoval R

In: Scandinavian Journal of Gastroenterology, 2011 Nov; 46(11):1369-80


Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.

Raziorrouh B, Ulsenheimer A, Schraut W, Heeg M, Kurktschiev P, Zachoval R, Jung MC, Thimme R, Neumann-Haefelin C, Horster S, Wächtler M, Spannagl M, Haas J, Diepolder HM, Grüner NH

In: Gastroenterology, 2011 Oct; 141(4):1422-31


Hepatitis A - combined prolonged biphasic and cholestatic course of disease

Schmidt L, Zachoval R, Diepolder H, Kolligs FT

In: Deutsche medizinische Wochenschrift, 2011 May; 136(20):1057-9


Arterial blood flow predicts graft survival in liver transplant patients

Pratschke S, Meimarakis G, Mayr S, Graeb C, Rentsch M, Zachoval R, Bruns CJ, Kleespies A, Jauch KW, Loehe F, Angele MK

In: Liver Transplantation, 2011 Apr; 17(4):436-45


The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.

Raziorrouh B, Gerlach T, Schraut W, Grüner NH, Ulsenheimer A, Zachoval R, Wächtler M, Spannagl M, Haas J, Diepolder HM, Jung MC

In: Hepatology, 2010 Dec; 52(6):1934-47


Comparing acoustic radiation force impulse imaging to transient elastography to assess liver stiffness in healthy volunteers with and without valsalva manoeuvre

Horster S, Mandel P, Zachoval R, Clevert DA

In: Clinical Hemorheology and Microcirculation, 2010; 46(2-3):159-68


FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.

Heeg MH, Ulsenheimer A, Grüner NH, Zachoval R, Jung MC, Gerlach JT, Raziorrouh B, Schraut W, Horster S, Kauke T, Spannagl M, Diepolder HM.

In: Gastroenterology, 2009 Oct; 137(4):1280-8


Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.

Vogel M, Deterding K, Wiegand J, Grüner NH, Baumgarten A, Jung MC, Manns MP, Wedemeyer H, Rockstroh JK, German Hepatitis Group, Hep-Net

In: Clinical Infectious Diseases, 2009 Jul; 49(2):317-9; author reply 319


The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.

Deterding K, Wiegand J, Grüner N, Hahn A, Jäckel E, Jung MC, Buggisch P, Galle P, Berg T, Hinrichsen H, Potthoff A, Zeuzem S, Cornberg M, Manns M, Wedemeyer H

In: Zeitschrift für Gastroenterology, 2009 Jun; 47(6):531-40


Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a.

Marcellin P, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Jin R, Gurel S, Lu ZM, Wu J, Popescu M, Hadziyannis S, Peginterferon alfa-2a in HBeAg-negative Chronic Hepatitis B Study Group

In: Gastroenterology, 2009 Jun; 136(7):2169-2179


Late appearance of hepatitis C virus RNA after needlestick injury: necessity for a more intensive follow-up.

Gruener NH, Heeg M, Obermeier M, Ulsenheimer A, Raziorrouh B, Diepolder H, Zachoval R, Jung MC

In: Infection Control and Hospital Epidemiology, 2009 Mar; 30(3):299-300


Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.

Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH

In: European Journal of Gastroenterology & Hepatology, 2008 Aug; 20(8):778-83


Two consecutive episodes of acute hepatitis C with different genotypes in a hemodialysis patient responsive to PEG-interferon monotherapy

Lederer S, Zachoval R, Hasholzner U, Schiffl H

In: Clinical Nephrology, 2008 Apr; 69(4):313-6


Recurrence of hepatitis C virus during leucocytopenia and spontaneous clearance after recovery from cytopenia: a case report.

Gruener NH, Raziorrouh B, Jung MC

In: Journal of Medical Case Reports, 2007 Dec; 1(1):169


Orellanus syndrome: a rare cause of acute renal failure.

Wessely M, Schönermarck U, Raziorrouh B, Jung MC, Samtleben W

In: Deutsche medizinische Wochenschrift, 2007 Sep; 132(37):1880-2


Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.

Gruener NH, Gerlach TJ, Ulsenheimer A, Diepolder HM, Wierenga E, Zachoval R, Heeg M, Pape GR, Jung MC

In: Vaccine, 2007 Jun; 25(26):4960-6


Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.

Nevens F, Zuckerman JN, Burroughs AK, Jung MC, Bayas JM, Kallinowski B, Rivas EF, Duvoux C, Neuhaus P, Saliba F, Buti M, Zarski JP, Pons F, Vanlemmens C, Hamtiaux V, Stoffel M

In: Liver Transplantation, 2006 Oct; 12(10):1489-95


Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.

Gerlach JT, Ulsenheimer A, Grüner NH, Jung MC, Schraut W, Schirren CA, Heeg M, Scholz S, Witter K, Zahn R, Vogler A, Zachoval R, Pape GR, Diepolder HM

In: Journal of Virology, 2005 Oct; 79(19):12425-33


Mehr Publikationen bei PubMed anzeigen…